A Study to Learn About the Study Medicine (PF-08653944) in People With Obesity or Overweight and Type 2 Diabetes (T2D)

A phase 3 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 1078 participants.

Also called NCT07400653

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 1,078 participants (enrolled count) (from the registry)
Sponsor
  • Pfizer Registry lists this organization as the lead sponsor
Registry
  • NCT NCT07400653
  • EU CT 2025-523975-48-00
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States, Argentina, Bulgaria, Canada, Czechia, Germany, Poland, Romania, Slovakia, Spain, United Kingdom (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT07400653. Randomized; double masking; primary purpose treatment. Start 2026-02-24 (actual); primary completion 2027-10-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Study to Learn About the Study Medicine (PF-08653944) in People With Obesity or Overweight and Type 2 Diabetes (T2D)
Condition
Obesity
Condition
Overweight and/or Obesity
Condition
Overweight
Condition
Diabetes, Type 2
Intervention (Drug)
PF-08653944
Intervention (Other)
Placebo
Lead sponsor
Pfizer (class: industry)

Record details

Record id
cardio:ct-nct07400653
Content hash
e810d0af52a44f6677d8af72f2ab32c541391e19e700cd3ecfa8ac0eeb900854